PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 0.9450
-0.0100 (-1.05%)
Sep 17, 2026, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 659.76 million as of September 17, 2026. Its market cap has decreased by -40.13% in one year.
Market Cap
659.76M
Enterprise Value
641.89M
Revenue
149.85M
Ranking
n/a
PE Ratio
90.95
Stock Price
0.95
ChartMarket Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 659.76M, an increase of 1,893.99%. That is a compound annual growth rate of 11.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 652.85M | -23.17% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 8.98B |
| 4DMedical | 2.12B |
| Imricor Medical Systems | 654.39M |
| EBR Systems | 207.14M |
| Aroa Biosurgery | 186.79M |
| EMVision Medical Devices | 161.28M |
| Saluda Medical | 104.59M |
| Lumos Diagnostics Holdings | 99.21M |